Author

F. Kelly

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

J. J. Tu· 1 shared J. Steppe· 1 shared M. Blasi· 1 shared P. Hughes· 1 shared R. Goswami· 1 shared S. M. Palmer· 1 shared S. N. Langel· 1 shared S. R. Permar· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

J. J. Tu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Oral Hsp90 inhibitor, SNX-5422, attenuates SARS-CoV-2 replication and dampens inflammation in airway cells.

R. Goswami, V. S. Russell, J. J. Tu, P. Hughes, F. Kelly, S. N. Langel, J. Steppe, S. M. Palmer, T. Haystead, M. Blasi, S. R. Permar

This study shows that the Hsp90 inhibitor SNX-5422 reduces SARS-CoV-2 replication and inflammation in airway cells, suggesting its potential as an early therapeutic.

bioRxiv · Feb 23, 2021Microbiology